NF-E2 Transcription Factor, p45 Subunit
"NF-E2 Transcription Factor, p45 Subunit" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A tissue-specific subunit of NF-E2 transcription factor that interacts with small MAF PROTEINS to regulate gene expression. P45 NF-E2 protein is expressed primarily in MEGAKARYOCYTES; ERYTHROID CELLS; and MAST CELLS.
MeSH Number(s)
D12.776.260.108.656.770
D12.776.260.235.750.770
D12.776.930.127.656.770
D12.776.930.316.750.770
Concept/Terms
NF-E2 Transcription Factor, p45 Subunit- NF-E2 Transcription Factor, p45 Subunit
- NF E2 Transcription Factor, p45 Subunit
- Nuclear Factor (Erythroid-Derived 2), 45kDa
- p45 NF-E2 Protein
- NF-E2 Protein, p45
- p45 NF E2 Protein
Below are MeSH descriptors whose meaning is more general than "NF-E2 Transcription Factor, p45 Subunit".
Below are MeSH descriptors whose meaning is more specific than "NF-E2 Transcription Factor, p45 Subunit".
This graph shows the total number of publications written about "NF-E2 Transcription Factor, p45 Subunit" by people in Harvard Catalyst Profiles by year, and whether "NF-E2 Transcription Factor, p45 Subunit" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 4 | 4 |
1996 | 0 | 3 | 3 |
1997 | 0 | 2 | 2 |
1998 | 0 | 4 | 4 |
1999 | 0 | 2 | 2 |
2000 | 0 | 1 | 1 |
2001 | 0 | 2 | 2 |
2002 | 0 | 1 | 1 |
2003 | 0 | 2 | 2 |
2004 | 0 | 1 | 1 |
2006 | 1 | 0 | 1 |
2008 | 0 | 1 | 1 |
2009 | 0 | 1 | 1 |
2010 | 0 | 1 | 1 |
2012 | 0 | 2 | 2 |
2013 | 2 | 0 | 2 |
2016 | 1 | 0 | 1 |
2017 | 0 | 1 | 1 |
2018 | 1 | 0 | 1 |
2019 | 1 | 1 | 2 |
2023 | 0 | 1 | 1 |
Below are the most recent publications written about "NF-E2 Transcription Factor, p45 Subunit" by people in Profiles.
-
The histone demethylase JMJD2C constitutes a novel NFE2 target gene that is required for the survival of JAK2V617F mutated cells. Leukemia. 2023 04; 37(4):919-923.
-
CEACAM3 decreases asthma exacerbations and modulates respiratory syncytial virus latent infection in children. Thorax. 2020 09; 75(9):725-734.
-
GATA-1: A potential novel biomarker for the differentiation of essential thrombocythemia and myelofibrosis. J Thromb Haemost. 2019 06; 17(6):896-900.
-
Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations. Blood. 2019 04 18; 133(16):1766-1777.
-
Epigenetic regulation of NFE2 overexpression in myeloproliferative neoplasms. Blood. 2018 05 03; 131(18):2065-2073.
-
Megakaryocytes compensate for Kit insufficiency in murine arthritis. J Clin Invest. 2017 May 01; 127(5):1714-1724.
-
NF-E2, FLI1 and RUNX1 collaborate at areas of dynamic chromatin to activate transcription in mature mouse megakaryocytes. Sci Rep. 2016 07 26; 6:30255.
-
A high concentration of triiodothyronine attenuates the stimulatory effect on hemin-induced erythroid differentiation of human erythroleukemia K562 cells. Endocr J. 2015; 62(5):431-40.
-
The effects of GATA-1 and NF-E2 deficiency on bone biomechanical, biochemical, and mineral properties. J Cell Physiol. 2013 Jul; 228(7):1594-600.
-
MPN patients harbor recurrent truncating mutations in transcription factor NF-E2. J Exp Med. 2013 May 06; 210(5):1003-19.